- Home
- ALTS vs LTRN Comparison
ALTS vs LTRN Comparison
Compare ALTS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- LTRN
- Stock Information
- Founded
- ALTS 1976
- LTRN 2013
- Country
- ALTS United States
- LTRN United States
- Employees
- ALTS N/A
- LTRN N/A
- Industry
- ALTS
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- LTRN Health Care
- Exchange
- ALTS NYSE
- LTRN Nasdaq
- Market Cap
- ALTS 159.4M
- LTRN 36.0M
- IPO Year
- ALTS N/A
- LTRN 2020
- Fundamental
- Price
- ALTS $7.88
- LTRN $3.74
- Analyst Decision
- ALTS
- LTRN Strong Buy
- Analyst Count
- ALTS 0
- LTRN 1
- Target Price
- ALTS N/A
- LTRN $25.00
- AVG Volume (30 Days)
- ALTS 309.3K
- LTRN 283.8K
- Earning Date
- ALTS 08-18-2025
- LTRN 08-07-2025
- Dividend Yield
- ALTS N/A
- LTRN N/A
- EPS Growth
- ALTS N/A
- LTRN N/A
- EPS
- ALTS N/A
- LTRN N/A
- Revenue
- ALTS $18,046,000.00
- LTRN N/A
- Revenue This Year
- ALTS $185.91
- LTRN N/A
- Revenue Next Year
- ALTS $64.93
- LTRN N/A
- P/E Ratio
- ALTS N/A
- LTRN N/A
- Revenue Growth
- ALTS N/A
- LTRN N/A
- 52 Week Low
- ALTS $1.29
- LTRN $2.55
- 52 Week High
- ALTS $10.95
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- ALTS 47.13
- LTRN 63.62
- Support Level
- ALTS $7.06
- LTRN $3.21
- Resistance Level
- ALTS $8.38
- LTRN $3.75
- Average True Range (ATR)
- ALTS 0.91
- LTRN 0.24
- MACD
- ALTS -0.17
- LTRN 0.07
- Stochastic Oscillator
- ALTS 33.51
- LTRN 98.65
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.